Skip to content

Faculty profile

James Whitlock

Back to faculty
ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Expression and Clinical Correlation of PD-1/PD-L1 and VE1(BRAFp.V600E) in Pediatric Langerhans Cell Histiocytosis.

    Mediterranean journal of hematology and infectious diseases · 2023

  • First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia.

    Cancer genetics · 2020

  • A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis.

    Pediatric blood & cancer · 2017

All 7 publications

Latest funding

  • Towards patient-centred precision oncology care for children and youth: Understanding psychosocial impacts and experiences through patient and professional perspectives

    CIHR · 2024 · Co-investigator

    $1,013,626
  • Planning and Implementation of a Multidisciplinary Participant Onboarding Program for ACCESS: the National Pediatric Cancer Consortium

    CIHR · 2024 · Principal investigator

    $10,000
  • Towards patient-centred precision oncology care for children and youth: Understanding value through patient and professional perspectives

    CIHR · 2023 · Co-investigator

    $100,000
All 7 grants and awards
Something wrong or missing on this profile? Suggest a correction